Bavarian Nordic (OTCMKTS:BVNRY) Shares Gap Up – What’s Next?

Shares of Bavarian Nordic (OTCMKTS:BVNRY) gapped up before the market opened on Monday . The stock had previously closed at $9.76, but opened at $10.00. Bavarian Nordic shares last traded at $10.00, with a volume of 264 shares.

Bavarian Nordic Trading Up 0.2%

The firm has a market cap of $2.38 billion, a P/E ratio of 6.46 and a beta of 1.37. The company’s fifty day moving average price is $10.36 and its two-hundred day moving average price is $10.89.

Bavarian Nordic (OTCMKTS:BVNRY) last announced its earnings results on Friday, November 14th. The company reported $0.72 earnings per share for the quarter. Bavarian Nordic had a return on equity of 20.47% and a net margin of 35.96%.The company had revenue of $281.11 million during the quarter. On average, analysts predict that Bavarian Nordic will post 0.67 EPS for the current fiscal year.

Bavarian Nordic Company Profile

Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.

The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.